Arogundade F A, Sanusi A A, Badmus T A, Ibrahim A, Akinsola A
Renal Unit, Department of Medicine, Obafemi Awolowo University, Ile-Ife, P. M. B 5538, Ile-Ife, Osun State, Nigeria.
Niger Postgrad Med J. 2006 Mar;13(1):26-30.
To highlight the indications, problems and prospects of bedside non-surgically inserted jugular and subclavian dual lumen catheters.
Renal failure patients being managed in our centre with indications for central catheterisation were consecutively recruited at presentation. They had bedside non-surgical jugular and subclavian insertion of central catheters using modified Seldinger wire technique and the performance of the catheters monitored.
Sixteen patients aged between 23 and 65 years had 32 central catheterizations during the 12-month period. The indications included its use as haemodialysis access in all catheterisations, additional indications were CVP monitoring in 5, and parenteral hyperalimentation in 1. Three catheterisations were in right subclavian vein, 4 in left internal jugular vein and 25 in right internal jugular vein. The duration of use ranged between 3 days and 11 weeks and blood flow rate used ranged between 250 and 350 mls/min. Nine (28.1%) catheterisations were complicated with exit site and systemic infection. Catheter blockage and accidental catheter removal were recorded in 3 patients each. Carotid artery puncture was recorded in 2 patients but haemostasis was maintained with direct digital compression.
We conclude that percutaneous bedside internal jugular and subclavian (venous) catheterisation using dual lumen catheter is safe and devoid of major complications.
强调床边非手术置入颈内静脉和锁骨下静脉双腔导管的适应证、问题及前景。
在我院就诊且有中心静脉置管适应证的肾衰竭患者在就诊时被连续纳入研究。采用改良Seldinger导丝技术在床边非手术方式置入颈内静脉和锁骨下静脉中心导管,并对导管性能进行监测。
16例年龄在23至65岁之间的患者在12个月期间共进行了32次中心静脉置管。所有置管的适应证均包括用作血液透析通路,另外5例用于中心静脉压监测,1例用于胃肠外高营养。3次置管于右锁骨下静脉,4次于左颈内静脉,25次于右颈内静脉。使用时间为3天至11周,血流量为250至350毫升/分钟。9次(28.1%)置管出现出口部位及全身感染并发症。3例患者出现导管堵塞,3例患者出现导管意外拔除。2例患者记录有颈动脉穿刺,但通过直接指压维持了止血。
我们得出结论,使用双腔导管经皮床边置入颈内静脉和锁骨下静脉(静脉)导管是安全的,且无重大并发症。